1. FCC ID
  2. 2AQBR
  3. 2AQBR-D071
  4. Test Report-Rev-231012

D071 Blood Glucose Monitoring System Test Report - FCC ID 2AQBR-D071

FCC ID 2AQBR-D071

Test Report-Rev-231012

Blood Glucose Monitoring System

by EPS Bio Technology Corp.

Document preview loads when visible.

Document Details

FCC ID2AQBR-D071
Document ID6863129
Document TypeTest Report
DescriptionTest Report-Rev-231012
Document TitleEPS Bio Technology Corp.
ApplicantEPS Bio Technology Corp.
Equipment ClassBlood Glucose Monitoring System
Product CodeD071
Application IDKlR2g9fe9ctP/XlBTDzsiA==
Application PurposeOriginal Equipment
Application Date2023-10-19
Frequency Range13.56 MHz
FRN0027661685
Test FirmAudix Technology Corporation
Certified ByBen Cheng
Short-Term ConfidentialityNo
Long-Term ConfidentialityNo
Grant DeferralNo
Modular EquipmentDoes not apply
Composite DeviceNo
Composite PartNo
Submitted2023-10-18
Available2023-10-19
Created2023-10-12
Modified2023-10-12
Pages32
File TypeAdobe Acrobat PDF
File Size1822930
File SHA-256d8872c2214d67909695e9972ff9c7fa28db09f80e6586bbfdfeadc728dbc05d8
PDF Metadata Authorannie_yu
PDF Metadata Producerannie_yu Microsoft® Word 2010
FCC.gov SourcesFCC.gov 6863129

Related FCC Exhibits

DocumentTypeAvailableFile
User Manual-EasyMax TagUsers Manual2023-10-19PDF 2.3 MB
User Manual-EcoUsers Manual2023-10-19PDF 4.7 MB
EUT Internal Photo-Rev01-231018Internal Photos2023-10-19PDF 1.8 MB
EUT External Photo-Rev01-231018External Photos2023-10-19PDF 705.9 KB
Label Format and LocationID Label/Location Info2023-10-19PDF 300.7 KB
Test Setup PhotoTest Setup Photos2023-10-19PDF 710.8 KB
Antenna DatasheetTest Report2023-10-19PDF 37.3 KB
Test Report-Rev-231012Test Report2023-10-19PDF 1.7 MB
ACB-Form-FCC-Application-Letters-Covered-List-AttestationAttestation Statements2023-10-19PDF 31.6 KB
ACB-Form-FCC-Application-Letters-U.S.-Agent-Letter-for-Service-of-Process-Rev01-Attestation Statements2023-10-19PDF 49.9 KB
ACB-Form-Application-Form-Letters-Confidentiality-LetterCover Letter(s)2023-10-19PDF 52.3 KB
ACB-Form-FCC-Authority to Act as Agent LetterCover Letter(s)2023-10-19PDF 28.2 KB
Authorization letter-HP to ZoeCover Letter(s)2023-10-19PDF 329.8 KB
Cover Letter-Family model declaration letterCover Letter(s)2023-10-19PDF 33.3 KB
RF Exposure Exclusion Evaluation-Rev01-231019RF Exposure Info2023-10-19PDF 120.9 KB
Confidential_Block Diagram Metadata onlyBlock DiagramPDF 63.4 KB
Confidential_Schematic Metadata onlySchematicsPDF 205.7 KB
Confidential_Operating Description Metadata onlyOperational DescriptionPDF 206.7 KB